143 related articles for article (PubMed ID: 578073)
1. Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
Di Chiara G; Vargiu L; Porceddu ML; Gessa GL
Adv Biochem Psychopharmacol; 1977; 16():443-6. PubMed ID: 578073
[No Abstract] [Full Text] [Related]
2. Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).
Di Chiara G; Porceddu ML; Vargiu L; Gessa GL
Pharmacology; 1978; 16 Suppl 1():135-42. PubMed ID: 643899
[TBL] [Abstract][Full Text] [Related]
3. Self-inhibitory dopamine-receptors and central effects of apomorphine.
Di Chiara G; Porceddu ML; Morelli M; Gessa GL
Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
[TBL] [Abstract][Full Text] [Related]
4. [Dopaminergic blockage using pimozide and dopaminergic stimulation using bromocryptin. Effect on secretion of somatotropin].
Hainer V; Krejcík L; Urbánek J; Tvaroh F
Cas Lek Cesk; 1977 Jan; 116(2):11-6. PubMed ID: 576415
[No Abstract] [Full Text] [Related]
5. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced dopaminergic supersensitivity.
Moore KE; Thornburg JE
Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
[No Abstract] [Full Text] [Related]
7. New central dopamine agonists.
Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):227-36. PubMed ID: 2999737
[TBL] [Abstract][Full Text] [Related]
8. Evidence for selective and long-lasting stimulation of "regulatory" dopamine-receptors by bromocriptine (CB 154).
di Chiara G; Porceddu ML; Vargiu L; Stefanini E; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):239-45. PubMed ID: 600311
[TBL] [Abstract][Full Text] [Related]
9. Evidence for dopamine receptors mediating sedation in the mouse brain.
Di Chiara G; Porceddu ML; Vargiu L; Argiolas A; Gessa GL
Nature; 1976 Dec; 264(5586):564-7. PubMed ID: 1004597
[No Abstract] [Full Text] [Related]
10. Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
Dolphin AC; Jenner P; Marsden CD; Sawaya MC
Br J Pharmacol; 1977 Mar; 59(3):467P. PubMed ID: 576587
[No Abstract] [Full Text] [Related]
11. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
Imperato A; Tanda G; Frau R; Di Chiara G
J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
[TBL] [Abstract][Full Text] [Related]
12. Hypothermic action of bromocriptine.
Calne DB; Claveria LE; Reid JL
Br J Pharmacol; 1975 May; 54(1):123-4. PubMed ID: 1139073
[TBL] [Abstract][Full Text] [Related]
13. Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
Ferrer JM; Sanguinetti AM; Vives F; Mora F
Pharmacol Biochem Behav; 1983 Aug; 19(2):211-7. PubMed ID: 6138775
[TBL] [Abstract][Full Text] [Related]
14. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes].
Skrinskaia IuA; Nikulina EM
Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935
[TBL] [Abstract][Full Text] [Related]
15. Anorectic effect of lisuride and other ergot derivatives in the rat.
Carruba MO; Ricciardi S; Müller EE; Mantegazza P
Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
Silbergeld EK; Pfeiffer RF
J Neurochem; 1977 Jun; 28(6):1323-6. PubMed ID: 577501
[No Abstract] [Full Text] [Related]
17. Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.
Di Chiara G; Vargiu L; Porceddu ML; Longoni R; Mulas A; Gessa GL
Adv Biochem Psychopharmacol; 1977; 16():571-5. PubMed ID: 18901
[No Abstract] [Full Text] [Related]
18. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Fuller RW; Clemens JA; Hynes MD
J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
[TBL] [Abstract][Full Text] [Related]
19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
20. The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents.
Dolphin AC; Jenner P; Sawaya MC; Marsden CD; Testa B
J Pharm Pharmacol; 1977 Dec; 29(12):727-34. PubMed ID: 22618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
